Joint Action EUROCAT 2011-2013 Funded by the Public Health Programme 2008-2013 of the European Commission

Ingeborg Barisic, Maria Loane, Rhonda M Curran, Ester Garne, Martine Vrijheid, Domenica Taruscio, Joan Morris, Marian Bakker, Lorentz Irgens, Elisa Calzolari, Babak Khoshnood, Diana Wellesley, Helen Dolk

Research output: Contribution to journalArticle

Abstract

Congenital anomalies (CA) are an important cause of morbidity and mortality in infants and children. More than 100,000 children with CA are born in EU each year. The European Surveillance of Congenital Anomalies (EUROCAT) is a network of population based congenital anomaly registries in Europe currently surveying 31% of EU birth population. EUROCAT has been awarded funding for 2011-2013 as a Joint Action between EU and member states. The Joint Action EUROCAT aims to use harmonised data on CA across EU to assess prevalence of all birth outcomes, the impact of primary prevention, and developments in prenatal screening. Joint Action EUROCAT will serve as an early warning of teratogen exposures, and act as an information centre regarding clusters, and exposures to risk factors of concern, including new medicine used in pregnancy, ail pollution, swine flu vaccination, and chronic maternal diseases as obesity and diabetes.
Original languageEnglish
Pages (from-to)25-32
JournalHrvatski časopis za javno zdravstvo
Volume8
Publication statusPublished - 2012

Fingerprint Dive into the research topics of 'Joint Action EUROCAT 2011-2013 Funded by the Public Health Programme 2008-2013 of the European Commission'. Together they form a unique fingerprint.

  • Cite this